What EBNA IgG can tell you
A high EBNA IgG result often means an infection from months or years ago. It does not mean EBV is active again. The full antibody panel, illness dates, immune health, and transplant plans give the result meaning.
What it finds
It checks an antibody to EBNA-1
The blood test finds an antibody to part of EBV called EBNA-1. It does not count active virus.
Why it is useful
It helps place the infection in time
EBNA helps read VCA IgM and VCA IgG during a mono-like illness or before treatment that weakens the immune system.
What a high result means
A high result can come from an old infection
It cannot show active virus or prove that EBV causes fatigue, thinking trouble, or pain.
Repeating EBNA IgG to see whether it falls does not measure recovery. If symptoms continue, use the actual clinical problem to choose the next assessment.
Save this test
Save the antibody panel, not an activity score
Save EBNA IgG with both VCA results, illness dates, immune health, lab method, and the clinician's reading.
Save the panel once. Add a new note only if another test or care decision changes the picture.
How age, pregnancy, and immune health affect this test
Labs use their own EBNA IgG cutoffs. There are no separate healthy targets for age or sex. Age, pregnancy, immune health, and transplant care change how the result is used.
Children and teenagers
Many children get EBV without classic mono. Teens and young adults are more likely to have mono after a first infection. In US data, past EBV became much more common from ages 6 to 19. Monospot often misses EBV in young children, so an EBV antibody panel may help.
Pregnancy and breastfeeding
The blood draw needs no special steps during pregnancy. EBNA IgG is not a routine test of risk to the baby. Tell the clinician about fever, dehydration, liver problems, medicines, and other possible infections. Mayo has not set this test for newborn or cord blood.
Men and women
There is no separate EBNA IgG cutoff for men and women. A 2025 study of 387 people found no sex difference in IgG from past infection. It did not create different lab ranges.
Older adults
Most older adults have had EBV, so positive EBNA IgG is common. New fatigue or thinking trouble still needs checks for medicines, sleep, anemia, thyroid disease, blood sugar, or brain and nerve problems.
Immune suppression and transplant
A weak immune system or blood products can make antibodies late, weak, or hard to read. Before transplant or immune treatment, IgG may show past exposure. After transplant, teams may use a set EBV DNA plan instead of repeating EBNA IgG.
Before an EBNA IgG blood test
Ask why the test is being done. It can help sort a recent infection from a past one or clear up an unusual panel. It may also record past exposure before a transplant or immune-weakening medicine.
Ask for the full panel. Save VCA IgM, VCA IgG, EBNA IgG, the lab's full reading, and any advice to repeat the test. EA-D or EBV DNA has a separate job.
Note the day fever, sore throat, swollen glands, rash, strong fatigue, or belly pain began. EBNA usually appears later than VCA antibodies, so the blood-draw date matters.
Tell the clinician about HIV, a transplant, cancer care, medicines that weaken the immune system, an immune disorder, blood products, or immunoglobulin treatment. These can change the antibody results.
This blood test needs no special diet. Follow any separate instructions for other tests ordered at the same visit.
If recent mono is possible, ask about a CBC, liver tests, and an exam for an enlarged liver or spleen. EBNA IgG cannot check dehydration, breathing, liver injury, low platelets, or spleen risk.
Put the result back into the panel
Save VCA IgM, VCA IgG, and EBNA IgG together with each lab call. Do not read the EBNA number alone.
Add the illness date
Write the first day of illness and the blood-draw date. A negative EBNA result early in illness differs from a negative result months later.
Check whether the combination is typical
VCA IgG and EBNA IgG with no VCA IgM usually means past infection. EBNA alone, lasting VCA IgM, all markers positive, or an unclear result may need another test.
Ask what decision follows
Ask whether the result shows a recent infection, past infection, no past infection, or risk before immune treatment. Repeat it only when the answer will change care.
How to read EBNA IgG with the EBV antibody panel
Start with each lab call. Put EBNA beside VCA IgM, VCA IgG, illness dates, immune health, and any advice to repeat the test. Do not compare numbers from different labs.
VCA IgG positive, EBNA IgG positive, VCA IgM negative
This common combination usually means an EBV infection from months or years ago. A high EBNA IgG number does not show a recent infection or active virus.
EBNA IgG equivocal or an atypical combination
Check the lab calls, VCA results, symptom dates, and immune health. Mayo advises a repeat in 10 to 14 days for some unclear results. A different test, immunoblot, avidity, or EBV DNA may help when the answer will change care.
VCA IgM positive, VCA IgG positive, EBNA IgG negative
This supports a recent first EBV infection when it fits the illness. EBNA can still be negative early, and rare active infections may have no clear EBV antibodies.
It can stay high for years
The CDC says more than 90 percent of adults have had EBV. High antibody levels may last for years.
See research details
The research details explain when EBNA appears, why test methods can differ, how to read unusual results, and when a rare long-lasting EBV illness needs specialist care.
Do not use a high EBNA IgG number to diagnose recent infection, reactivation, chronic EBV, or the cause of brain fog.
Use the actual laboratory method and the full panel. Do not assign an exact infection date from EBNA alone.
If only EBNA is positive, it may be real but isn't typical of past infection. Review or confirm it before using it to explain symptoms.
Children and teenagers are less uniformly exposed than adults. A negative panel can still mean they haven't had EBV. Read a positive result with age and symptoms.
Do not invent male or female EBNA IgG targets. Use the same laboratory interpretation and the person's clinical context.
Persistent fever, enlarged liver or spleen, low blood counts, hepatitis, swollen nodes, or organ disease needs specialist assessment. EBNA IgG can't diagnose this rare condition.
How to care for yourself while you recover
Do not try to lower EBNA IgG with food or supplements. Care for the illness you have now, keep the full panel together, and check other causes if symptoms last.
If mono is current, protect recovery
Drink enough fluid, rest as needed, and follow the plan for pain or fever. Avoid contact sports until a clinician says it is safe because an enlarged spleen can tear.
Keep a short illness and recovery record
Write down fever, throat pain, swollen glands, rash, belly pain, sleep, fluids, activity, and whether fatigue gets better each week. Add the test dates.
Check other causes when symptoms persist
If illness lasts more than six months without lab proof of EBV, the CDC advises checking other causes. Ask about medicines, sleep, blood counts, liver health, thyroid, iron, B12, mood, autonomic symptoms, or another infection.
Do not treat a high antibody number
Do not start an antiviral, immune product, lysine, herbs, binders, fasting, a strict diet, or high-dose supplements because EBNA IgG is high. First ask what illness needs treatment.
Get urgent help for severe or sudden pain in the upper-left belly, fainting, or trouble breathing or swallowing. Marked dehydration, severe weakness, confusion, a seizure, jaundice, unusual bleeding, or fast worsening also needs urgent care. Do not wait for another EBV antibody result.
What to save before the next appointment
Keep these together
- EBNA IgG lab call and number, unit, cutoff, lab, test method, and blood-draw date.
- VCA IgM, VCA IgG, EA-D IgG if ordered, and the lab's full reading.
- First day of fever, sore throat, swollen glands, rash, strong fatigue, belly pain, and the recovery course.
- Immune-suppressing medicines, transplant or cancer treatment, immune deficiency, recent blood products, and immunoglobulin treatment.
- CBC, liver tests, examination findings, other infection tests, repeat plan, activity restrictions, and the decision the panel changed.
Question for the visit
“Ask whether all three antibody results show a recent infection, past infection, no past infection, or an unclear result. Ask whether another test would change your care.”
Sources for EBNA IgG (Epstein-Barr Nuclear Antigen IgG)
Guide sections: CDC past-infection pattern; Timing depends on method and person; Older adults; Check other causes when symptoms persist; Do not treat a high antibody number
Guide sections: If mono is current, protect recovery; Keep a short illness and recovery record
Guide sections: Timing depends on method and person; Children and teenagers; Pregnancy and breastfeeding; Immune suppression and transplant
Guide sections: Immune suppression and transplant
Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
Sex Differences in Anti-Epstein-Barr Virus Antibody Responses.
Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.
Updated guidelines for chronic active Epstein-Barr virus disease.
See each claim's sources
interpretation
Standard-immunofluorescent EBNA antibody is absent in acute infection, appears about two to four months after symptoms, and then persists; VCA plus EBNA usually indicates past infection, and high levels may remain for years.procedure
Mayo's current ELISA profile reads EBNA with both viral-capsid antibodies, reports assay-specific categories, and recommends selected equivocal patterns be repeated in 10 to 14 days when clinically indicated.limitation
In the 2024 Portet study, complementary testing resolved immune status in more than 98.5 percent of atypical cases, supporting confirmation when an isolated or discordant antibody pattern does not fit the history.context
The 2025 Jackson study found its largest sex differences in other antibody-response groups rather than latent IgG, so it does not provide a basis for male or female EBNA targets.context
The Balfour NHANES analysis found that prior EBV exposure rose sharply across childhood and adolescence in the United States, so age changes the chance that a positive antibody reflects an earlier infection.safety
The 2023 Kawada guideline proposes at least 10,000 IU/mL EBV DNA in whole blood as one CAEBV criterion but also requires compatible disease and identification of EBV-infected T or NK cells; EBNA IgG cannot diagnose CAEBV.